Front view of Ildong Bioscience headquarters.

Front view of Ildong Bioscience headquarters.

View original image


[Asia Economy Reporter Lee Gwan-joo] Ildong Bioscience, a health functional food business company of Ildong Pharmaceutical Group, announced on the 28th that it has been selected as a '2022 Youth-Friendly Small Giant Company' hosted by the Ministry of Employment and Labor and the Korea Employment Information Service.

?

Youth-Friendly Small Giant Companies are small giants with high credit rating and employment retention rates, and no industrial accident deaths within three years. They are companies with excellent wages and 'Work-Life Balance' (Work-Life Balance), making them good workplaces for young people.

?

In this evaluation, Ildong Bioscience received excellent scores in terms of wages, employment stability, and work-life balance, and has been selected as a Youth-Friendly Small Giant Company for three consecutive years since its first selection in 2020.

?

The company explained that it received good evaluations especially for improving working conditions through expanding youth recruitment and maintaining employment stability, encouraging punctual attendance and flexible work, and operating a flexible vacation system. It also added that it was recognized for creating a good working environment through reasonable compensation, education and training support, and operation of various welfare systems and facilities. Companies designated as Youth-Friendly Small Giant Companies receive advantages such as preferential selection for government-led small and medium enterprise support projects, financial support, and financial benefits.



A representative of Ildong Bioscience said, “The satisfaction and happiness of members are important factors directly linked to the company's development,” and added, “We plan to pay attention to efforts to create a good workplace as well as to provide quality jobs for young people.”

?

?Ildong Bioscience is a health functional food specialized company established in 2016 as a subsidiary of Ildong Holdings based on Ildong Pharmaceutical's original technology and infrastructure related to probiotics, supplying probiotic raw materials and products to leading domestic and international companies.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing